ArticleFrontiers in molecular biosciences2026
A network-driven computational framework for identifying FDA-approved drug repurposing across heterogeneous brain cancers.
Om PrakashPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it